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Summary 
 
A nursery study was conducted at the KSU 
Segregated Early-Weaning Facility to evaluate 
the effect of dietary arabinogalactan on 
weanling pig performance. Arabinogalactan is 
a water-soluble proteoglycan/polysaccharide, 
most commonly harvested from the bark of 
the Western Larch (Larix occidentalis) tree, 
which has demonstrated neutraceutical proper-
ties in a limited number of studies with dogs 
and foals. A total of 288 pigs (initially 14.9 lb) 
were used in the 35-d experiment. Pigs were 
blocked by weight and randomly allotted to 
one of eight dietary treatments fed throughout 
Phase 1 (d 0 to 14) and Phase 2 (d 14 to 28), 
followed by a common diet during Phase 3 (d 
28 to 35). Four levels of arabinogalactan (0, 
0.05, 0.10, and 0.20%) were included in either 
a negative or positive control diet in a 2 × 4 
factorial to form the eight dietary treatments. 
The negative control diet was a corn-soybean 
meal based diet without feed-grade antibiotics. 
The positive control diet was identical to the 
negative control, but contained a feed-grade 
antibiotic (Neo-Terramycin with 140 g of 
neomycin and 140 g of oxytetracycline per 
ton). The common diet fed during Phase 3 did 
not contain arabinogalactan, but did contain a 
feed-grade antibiotic (Neo-Terramycin). From 
d 0 to 14 (Phase 1), ADG, ADFI, and d 14 
weight decreased (linear, P<0.05) with in-
creasing level of arabinogalactan in the diet. 
Also, pigs fed the positive control diet were 
heavier (P<0.05) on d 14 than those fed the 
negative control. During Phase 2 (d 14 to 28) 
and for the overall treatment period (d 0 to 
28), ADG, ADFI, and d 28 weight were im-
proved (P<0.01) for pigs fed the positive con-
trol diet compared with pigs fed the negative 
control. Due to the reduction in ADFI at the 
highest level (0.20%) of arabinogalactan, 
ADFI decreased (linear, P<0.05) from d 0 to 
28 with increasing arabinogalactan. From d 28 
to 35 (Phase 3), when all pigs were fed a 
common diet, ADG and F/G were poorer for 
pigs previously fed the positive control. Over-
all (d 0 to 35), ADG tended to be improved 
(P<0.07), and ADFI and d 35 weight were 
improved (P<0.05) for pigs fed the positive 
control, but F/G was slightly poorer (P<0.05) 
than for pigs fed the negative control. A re-
duction (linear, P<0.05) in ADFI was ob-
served for pigs fed increasing arabinogalactan.  
In conclusion, the addition of arabinogalactan 
to weanling pig diets did not improve growth 
performance with the high level (0.20%) re-
sulting in reduced ADFI. However, ADG, 
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ADFI, and d 35 weight were improved by in-
cluding a feed-grade antibiotic in the Phase 1 
and Phase 2 diets. 
 
(Key words:  antibiotics, arabinogalactan.) 
 
Introduction 
 
There is increasing public concern about 
the use of sub-therapeutic levels of feed-grade 
antibiotics in food animal production.  The 
judicious use of sub-therapeutic (or more 
commonly “growth promoter”) levels of anti-
biotics in food animal production has served 
to improve animal health, welfare, and per-
formance/production efficiency.  Most often, 
the use of these feed-grade antibiotics coin-
cides with periods of increased stress, such as 
weaning. 
 
As an alternative to feed-grade antibiotics, 
there is increasing interest in identifying suit-
able nutraceutical compounds. Nutricines are 
“natural” compounds found in various food-
stuffs in trace amounts, with properties that 
may improve health and immune function but 
lack an established requirement. An increasing 
understanding of potential nutraceutical com-
pounds that may enhance immunity and 
health, and improve the ability to cope with 
periods of increased stress has stimulated in-
terest in identifying suitable antibiotic re-
placements.  Few nutraceuticals, however, 
have been evaluated in studies measuring 
animal performance. 
 
Arabinogalactan is a naturally occurring, 
water-soluble proteoglycan/polysaccharide 
that is not generally found in foodstuffs com-
monly fed to domesticated pigs. A few ex-
periments with dogs and young foals have 
identified improvements in the digestive 
health and immune function of animals sup-
plemented with arabinogalactan in their diet. 
Weanling pigs are particularly vulnerable to 
enteric diseases and digestive upset, and these 
contribute significantly to losses in growth 
 
performance during the nursery period. A 
large portion of the “growth promoter” levels 
of feed-grade antibiotics used in the swine in-
dustry are used during this period due to their 
demonstrated efficacy in nursery pigs. There-
fore, the objective of this experiment was to 
evaluate the influence of dietary arabinogalac-
tan on the growth performance of weanling 
pigs. 
 
Procedures 
 
Procedures used in this experiment were 
approved by the Kansas State University 
Animal Care and Use Committee.  The project 
was conducted at the KSU Segregated Early-
Weaning Facility. Pens had steel ‘tri-bar’ 
flooring and provided approximately 3 ft2 per 
pig. Each pen was equipped with a four-hole, 
dry, self-feeder and one cup waterer, provid-
ing ad libitum access to feed and water.  The 
facility was a mechanically ventilated room 
with a pull-plug manure storage pit under-
neath the pens’ mesh flooring. 
 
A total of 288 pigs were weaned at an av-
erage of 14.9 lb and 21 d of age. Pigs were 
blocked by weight and randomly allotted to 
one of the eight dietary treatments with eight 
pens per treatment. Each pen contained either 
4 or 5 pigs. Two control diets were used. The 
negative control diet did not contain any feed-
grade antibiotics, while the positive control 
diet contained a feed-grade antibiotic (Neo-
Terramycin with 140 g of neomycin and 140 g 
of oxytetracycline per ton). Arabinogalactan 
(Larafeed® AG; to provide 0, 0.05, 0.10 and 
0.20% arabinogalactan) was added to each 
control diet at the expense of corn starch to 
achieve the eight dietary treatments. Experi-
mental diets were fed in meal form and main-
tained throughout two dietary phases (Table 
1). Phase 1 diets were fed from d 0 to 14 and 
Phase 2 diets were fed from d 14 to 28.  All 
pigs were fed a common diet that contained a 
feed-grade antibiotic (Neo-Terramycin with 
140 g of neomycin and 140 g of oxytetracy- 
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cline per ton) during Phase 3 (d 28 to 35). Pigs 
and feeders were weighed on d 0, 7, 14, 21, 
28, and 35 post-weaning to determine the re-
sponse criteria of ADG, ADFI, and F/G. 
For the overall treatment period (d 0 to 
28), ADG and ADFI were improved for pigs 
fed the positive control. Because of the lower 
ADFI for pigs fed the diet containing the 
highest level (0.20%) of arabinogalactan, 
ADFI decreased linearly (P<0.05) with in-
creasing arabinogalactan. 
 
Data were analyzed as a randomized com-
plete block design using the PROC MIXED 
procedure of SAS with pen as the experimen-
tal unit.  Linear and quadratic polynomial con-
trasts were used to determine the effects of 
increasing arabinogalactan. 
 
From d 28 to 35 (Phase 3), when all pigs 
were fed a common diet, ADG and F/G were 
poorer (P<0.01) for pigs previously fed the 
positive control diet.   
Results  
 Overall (d 0 to 35), ADG tended to be im-
proved (P<0.07) for pigs fed the positive con-
trol. Also, ADFI and d 35 weight were im-
proved (P<0.05) for pigs fed the positive con-
trol, but F/G was slightly poorer (P<0.05). A 
reduction (linear, P<0.05) in ADFI was ob-
served for pigs fed increasing arabinogalactan, 
primarily at the highest level (0.20%). 
There were no interactions (P>0.10) be-
tween the control diet and arabinogalactan 
(Tables 2 and 3). For the d 0 to 14 (Phase 1) 
period, ADG, ADFI, and d 14 weight de-
creased (linear, P<0.05) with increasing ara-
binogalactan in the diet. This was primarily 
due to the large reductions observed at the 
highest level fed (0.20%). Also, pigs fed the 
positive control diet had heavier (P<0.05) d 14 
weights than those fed the negative control. 
  
In conclusion, the addition of arabinoga-
lactan to weanling pig diets did not improve 
growth performance. In fact, feeding the high-
est level (0.20%) resulted in reduced perform-
ance. However, ADG, ADFI, and d 35 weight 
were improved by including a feed-grade an-
tibiotic in the Phase 1 and Phase 2 diets. 
 
During Phase 2 (d 14 to 28), ADG, ADFI, 
and d 28 weight of pigs fed the positive con-
trol diet were improved compared with pigs 
fed the negative control diet. 
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Table 1.  Composition of Experimental Dietsa,b,c
Ingredient Phase 1 Negative Control
Phase 2 
Negative Control 
Phase 3 
Common 
Corn 50.67 59.85 58.01 
Soybean meal (46.5% CP) 30.13 35.05 34.85 
Select menhaden fish meal 3.75 - - 
Spray-dried edible whey 10.00 - - 
Corn starch 1.17 1.17 - 
Soybean oil 1.00 - 3.00 
Monocalcium P (21% P) 1.20 1.50 1.20 
Limestone 0.75 1.10 0.93 
Salt 0.35 0.35 0.35 
L-lysine HCl 0.30 0.30 0.30 
DL-methionine 0.13 0.13 0.15 
L-threonine 0.15 0.15 0.11 
Vitamin premix 0.25 0.25 0.25 
Trace mineral premix 0.15 0.15 0.15 
Antibioticc - - 0.70 
Total 100.00 100.00 100.00 
  
Calculated analysis  
Total lysine, % 1.55 1.45 1.44 
True digestible amino acids    
  Lysine, % 1.41 1.31 1.30 
  Isoleucine:lysine ratio, % 60 63 62 
  Leucine:lysine ratio, % 121 129 128 
  Methionine:lysine ratio, % 33 33 35 
  Met & Cys:lysine ratio, % 56 58 59 
  Threonine:lysine ratio, % 63 64 62 
  Tryptophan:lysine ratio, % 17 18 18 
  Valine:lysine ratio, % 66 69 69 
Protein, % 22.40 21.90 21.60 
ME, kcal/lb 1,514 1,492 1,560 
TID lysine: ME ratio, g/Mcal 4.22 3.98 3.78 
Ca, % 0.81 0.73 0.71 
P, % 0.70 0.65 0.65 
Available P, % 0.40 0.32 0.33 
aThe positive control contained a feed-grade antibiotic (140 g/ton of Neomycin and 140 g/ton of 
Oxytetracycline) at the expense of corn starch, but was otherwise identical to the negative control. 
bLarafeed® AG (to provide 0, 0.05, 0.10 and 0.20% arabinogalactan) was added to the basal diets 
at the expense of corn starch. 
cProvided 140 g/ton of Neomycin and 140 g/ton of Oxytetracycline. 
Table 2.  Growth Performance of Nursery Pigs Fed Increasing Arabinogalactan – Interactive Meansa,b,c
     P < 
 Negative Control Positive Control   Negative vs  Arabinogalactan 
Item   Arabinogalactan, % 0 0.05 0.10 0.20 0 0.05 0.10 0.20 SE Mean Positive Arabinogalactan Linear Quadratic
D 0 to  14              
  ADG, lb 0.34 0.37 0.32 0.31 0.38 0.38 0.41 0.31 0.04 0.08 0.10 0.05 - 
  ADFI, lb 0.43 0.43 0.39 0.39 0.44 0.44 0.48 0.39 0.03 0.08 0.06 0.02 - 
  F/G 1.32 1.19 1.28 1.25 1.19 1.20 1.16 1.60 0.15 - - - - 
D 14 to 28              
  ADG, lb 1.00 0.98 1.02 1.01 1.15 1.13 1.21 1.07 0.05 0.01 - - - 
  ADFI, lb 1.34 1.33 1.31 1.30 1.50 1.47 1.56 1.39 0.07 0.01 - - - 
  F/G 1.35 1.35 1.28 1.29 1.30 1.32 1.30 1.30 0.03 - - - - 
Overall, D 0 to 28              
  ADG, lb 0.67 0.68 0.67 0.66 0.76 0.75 0.81 0.68 0.04 0.01 - - - 
  ADFI, lb 0.89 0.88 0.85 0.85 0.96 0.95 1.02 0.88 0.05 0.01 0.08 0.04 - 
  F/G 1.32 1.30 1.27 1.28 1.27 1.28 1.26 1.31 0.02 - - - - 
D 28 to 35 (common diet)             
  ADG, lb 1.80 1.74 1.74 1.75 1.61 1.63 1.64 1.59 0.05 0.01 - - - 
  ADFI, lb 2.31 2.24 2.25 2.28 2.25 2.26 2.28 2.14 0.08 - - - - 
  F/G 1.28 1.29 1.29 1.30 1.41 1.39 1.39 1.35 0.03 0.01 - - - 
Overall, D 0 to 35              
  ADG, lb 0.90 0.89 0.88 0.88 0.93 0.92 0.98 0.85 0.04 0.07 0.10 0.09 - 
  ADFI, lb 1.17 1.15 1.13 1.13 1.22 1.21 1.27 1.12 0.05 0.01 0.07 0.04 - 
  F/G 1.30 1.29 1.28 1.28 1.31 1.31 1.30 1.32 0.02 0.04 - - - 
Pig Weights, lb              
  D 0 14.9 14.9 14.9 14.9 14.9 14.9 14.9 14.9 0.70 - - - - 
  D 14 19.7 20.1 19.3 19.3 20.3 20.2 20.6 19.3 1.04 0.05 0.13 0.05 - 
  D 28 33.7 33.8 33.6 33.5 36.5 36.4 37.5 35.1 1.62 0.01 - - - 
  D 35 46.3 46.0 45.8 45.7 47.7 47.8 49.0 46.2 1.81 0.01 - - - 
aA total of 288 pigs were used in a 35-day experiment with eight replications and 4 or 5 pigs per pen. Experimental diets were fed in two phases, with 
phase 1 from d 0 to 14 after weaning and phase 2 from d 14 to 28. A common diet containing an antibiotic (Neo-Terramycin with 140 g of neomycin and 
140 g of oxytetracycline per ton) was fed during the third phase from d 28 to 35. 
bThe negative control diet did not contain a feed-grade antibiotic. The positive control diet contained a feed-grade antibiotic (Neo-Terramycin with 140 g 
of neomycin and 140 g of oxytetracycline per ton). 
cNo interactions, P>0.10 
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Table 3.  Growth Performance of Nursery Pigs Fed Increasing Arabinogalactan – Main Effectsa,b,c
P <       
 Control  Arabinogalactan, %   Arabinogalactan 
Item Negative Positive 0 0.05 0.10 0.20 SE Mean 
Negative vs 
Positive Arabinogalactan Linear Quadratic 
D 0 to 14            
  ADG, lb 0.34 0.37 0.36 0.38 0.36 0.31 0.04 0.08 0.10 0.05 - 
  ADFI, lb 0.41 0.44 0.44 0.43 0.43 0.39 0.03 0.08 0.06 0.02 - 
  F/G 1.26 1.29 1.26 1.20 1.22 1.42 0.15 - - - - 
D 14 to 28            
  ADG, lb 1.00 1.14 1.08 1.05 1.11 1.04 0.05 0.01 - - - 
  ADFI, lb 1.32 1.48 1.42 1.40 1.44 1.34 0.07 0.01 - - - 
  F/G 1.32 1.30 1.32 1.33 1.29 1.30 0.03 - - - - 
Overall, D 0 to 28            
  ADG, lb 0.67 0.75 0.72 0.71 0.74 0.67 0.04 0.01 - - - 
  ADFI, lb 0.86 0.95 0.93 0.91 0.93 0.86 0.05 0.01 0.08 0.04 - 
  F/G 1.29 1.28 1.29 1.29 1.27 1.29 0.02 - - - - 
D 28 to 35 (common diet)           
  ADG, lb 1.76 1.62 1.70 1.68 1.69 1.67 0.05 0.01 - - - 
  ADFI, lb 2.27 2.23 2.28 2.25 2.27 2.21 0.08 - - - - 
  F/G 1.29 1.38 1.34 1.34 1.34 1.33 0.03 0.01 - - - 
Overall, D 0 to 35            
  ADG, lb 0.89 0.92 0.91 0.91 0.93 0.87 0.04 0.07 0.10 0.09 - 
  ADFI, lb 1.15 1.21 1.19 1.18 1.20 1.13 0.05 0.01 0.07 0.04 - 
  F/G 1.29 1.31 1.31 1.30 1.29 1.30 0.02 0.04 - - - 
Pig Weights, lb            
  D 0 14.9 14.9 14.9 14.9 14.9 14.9 0.70 - - - - 
  D 14 19.6 20.1 20.0 20.1 20.0 19.3 1.04 0.05 0.13 0.05 - 
  D 28 33.7 36.4 35.1 35.1 35.6 34.3 1.62 0.01 - - - 
  D 35 46.0 47.7 47.0 46.9 47.4 46.0 1.81 0.01 - - - 
aA total of 288 pigs were used in a 35-day experiment with eight replications and 4 or 5 pigs per pen. Experimental diets were fed in two phases, with 
phase 1 from d 0 to 14 after weaning and phase 2 from d 14 to 28. A common diet containing an antibiotic (Neo-Terramycin with 140 g of neomycin and 
140 g of oxytetracycline per ton) was fed during the third phase from d 28 to 35. 
bThe negative control diet did not contain a feed-grade antibiotic. The positive control diet contained a feed-grade antibiotic (Neo-Terramycin with 140 g 
of neomycin and 140 g of oxytetracycline per ton). 
cNo interactions, P>0.10 
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